Valsartan/Hydrochlorothiazide
Valsartan/Hydrochlorothiazide is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hypertension and Cardiovascular Risk Factors
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
Clinical Trials (8)
Hypertension and Cardiovascular Risk Factors
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8